MicroRNA-29b has been shown to target and knock down expression of both DNMT3A and DNMT3B in cancer cells, with a consequent decrease in genome-wide methylation (Fabbri et al, 2007; Garzon et al, 2009). This evidence concerns the gene DNMT3B and cancer.